KMT2B and metabolic dysfunction-associated steatotic liver disease: In summary, we have identified two ENU induced point mutations M2628K and F2628I in MLL2 that give rise to a novel murine model of insulin resistance, impaired glucose tolerance and primary stages of NAFLD.